Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • International Stem Cell's Non-Current Assets fell 840.24% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 641.35%. This contributed to the annual value of $1.6 million for FY2024, which is 1369.72% down from last year.
  • International Stem Cell's Non-Current Assets amounted to $1.5 million in Q3 2025, which was down 840.24% from $1.7 million recorded in Q2 2025.
  • International Stem Cell's 5-year Non-Current Assets high stood at $3.0 million for Q1 2021, and its period low was $1.5 million during Q3 2025.
  • Its 5-year average for Non-Current Assets is $2.1 million, with a median of $2.1 million in 2023.
  • As far as peak fluctuations go, International Stem Cell's Non-Current Assets crashed by 2388.2% in 2021, and later surged by 56.31% in 2025.
  • International Stem Cell's Non-Current Assets (Quarter) stood at $2.6 million in 2021, then decreased by 16.85% to $2.2 million in 2022, then dropped by 13.95% to $1.9 million in 2023, then dropped by 13.7% to $1.6 million in 2024, then dropped by 4.03% to $1.5 million in 2025.
  • Its Non-Current Assets stands at $1.5 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.8 million for Q1 2025.